Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP616444.RAT4MSyMrybLIuUzaE821Jxmf7WcowAwGa74pWZUEkl1U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP616444.RAT4MSyMrybLIuUzaE821Jxmf7WcowAwGa74pWZUEkl1U130_assertion type Assertion NP616444.RAT4MSyMrybLIuUzaE821Jxmf7WcowAwGa74pWZUEkl1U130_head.
- NP616444.RAT4MSyMrybLIuUzaE821Jxmf7WcowAwGa74pWZUEkl1U130_assertion description "[In patients with endometrial carcinoma who did not receive radiotherapy or chemotherapy before surgery, the presence of decreased levels of pRb2/p130 in tumor cells is associated with a significantly increased risk of recurrence and death of disease, independent of tumor stage and ploidy status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616444.RAT4MSyMrybLIuUzaE821Jxmf7WcowAwGa74pWZUEkl1U130_provenance.
- NP616444.RAT4MSyMrybLIuUzaE821Jxmf7WcowAwGa74pWZUEkl1U130_assertion evidence source_evidence_literature NP616444.RAT4MSyMrybLIuUzaE821Jxmf7WcowAwGa74pWZUEkl1U130_provenance.
- NP616444.RAT4MSyMrybLIuUzaE821Jxmf7WcowAwGa74pWZUEkl1U130_assertion SIO_000772 9508194 NP616444.RAT4MSyMrybLIuUzaE821Jxmf7WcowAwGa74pWZUEkl1U130_provenance.
- NP616444.RAT4MSyMrybLIuUzaE821Jxmf7WcowAwGa74pWZUEkl1U130_assertion wasDerivedFrom befree-20140225 NP616444.RAT4MSyMrybLIuUzaE821Jxmf7WcowAwGa74pWZUEkl1U130_provenance.
- NP616444.RAT4MSyMrybLIuUzaE821Jxmf7WcowAwGa74pWZUEkl1U130_assertion wasGeneratedBy ECO_0000203 NP616444.RAT4MSyMrybLIuUzaE821Jxmf7WcowAwGa74pWZUEkl1U130_provenance.